Emmanuel Hernandez Alvarado, Laura Melisa Román Marín, Carlos Cuellar Ramos, Patricia Vieyra Reyes, H. Mendieta Zerón, Virgilio Trujillo Condes
{"title":"2型糖尿病患者的听力阈值","authors":"Emmanuel Hernandez Alvarado, Laura Melisa Román Marín, Carlos Cuellar Ramos, Patricia Vieyra Reyes, H. Mendieta Zerón, Virgilio Trujillo Condes","doi":"10.4103/AMJM.AMJM_54_21","DOIUrl":null,"url":null,"abstract":"Background: Type 2 diabetes mellitus (T2DM) leads to multiple chronic complications in the body including sensory functions. Aim: The aim of this study was to determine the hearing threshold in middle-aged patients with T2DM and categorize it according to the presence or absence of hearing loss. Materials and Methods: A prospective, cross-sectional study was performed with 40 patients with T2DM (mean age 58 ± 8.6 years and mean time of T2DM evolution 11.9 ± 8.2 years) and 40 nondiabetic subjects (mean age of 52.4 ± 10.9 years). Pure tone audiometry was performed with a Grason-Stadler GSI 18 screening audiometer, 11 frequencies (0.125–8 kHz) were evaluated and classified as low, medium, and high. Hearing loss was defined as a hearing threshold >20 decibels (dB) and was classified as: mild: 21–40 dB, moderate: 41–70 dB, severe: 71–90 dB, and profound: > 90 dB. Results: Compared to the control group, diabetic patients presented a significant increase in the hearing threshold at medium (P < 0.05) and high (P < 0.0001) audiometric frequencies. When hearing loss was present, it was almost entirely mild (>80%) in the control group, whereas diabetic patients presented moderate, severe, and even profound levels of hearing loss. A linear correlation was found between the diagnosis time of T2DM and the degree of hearing loss at high frequencies (P = 0.04) as well as at medium frequencies (P = 0.01). Conclusions: T2DM affects hearing from the early stages of the disease; routine evaluation of hearing function should be considered in this population.","PeriodicalId":138060,"journal":{"name":"Amrita Journal of Medicine","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Degree of Hearing Threshold in Patients with Type 2 Diabetes Mellitus\",\"authors\":\"Emmanuel Hernandez Alvarado, Laura Melisa Román Marín, Carlos Cuellar Ramos, Patricia Vieyra Reyes, H. Mendieta Zerón, Virgilio Trujillo Condes\",\"doi\":\"10.4103/AMJM.AMJM_54_21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Type 2 diabetes mellitus (T2DM) leads to multiple chronic complications in the body including sensory functions. Aim: The aim of this study was to determine the hearing threshold in middle-aged patients with T2DM and categorize it according to the presence or absence of hearing loss. Materials and Methods: A prospective, cross-sectional study was performed with 40 patients with T2DM (mean age 58 ± 8.6 years and mean time of T2DM evolution 11.9 ± 8.2 years) and 40 nondiabetic subjects (mean age of 52.4 ± 10.9 years). Pure tone audiometry was performed with a Grason-Stadler GSI 18 screening audiometer, 11 frequencies (0.125–8 kHz) were evaluated and classified as low, medium, and high. Hearing loss was defined as a hearing threshold >20 decibels (dB) and was classified as: mild: 21–40 dB, moderate: 41–70 dB, severe: 71–90 dB, and profound: > 90 dB. Results: Compared to the control group, diabetic patients presented a significant increase in the hearing threshold at medium (P < 0.05) and high (P < 0.0001) audiometric frequencies. When hearing loss was present, it was almost entirely mild (>80%) in the control group, whereas diabetic patients presented moderate, severe, and even profound levels of hearing loss. A linear correlation was found between the diagnosis time of T2DM and the degree of hearing loss at high frequencies (P = 0.04) as well as at medium frequencies (P = 0.01). Conclusions: T2DM affects hearing from the early stages of the disease; routine evaluation of hearing function should be considered in this population.\",\"PeriodicalId\":138060,\"journal\":{\"name\":\"Amrita Journal of Medicine\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Amrita Journal of Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/AMJM.AMJM_54_21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Amrita Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/AMJM.AMJM_54_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Degree of Hearing Threshold in Patients with Type 2 Diabetes Mellitus
Background: Type 2 diabetes mellitus (T2DM) leads to multiple chronic complications in the body including sensory functions. Aim: The aim of this study was to determine the hearing threshold in middle-aged patients with T2DM and categorize it according to the presence or absence of hearing loss. Materials and Methods: A prospective, cross-sectional study was performed with 40 patients with T2DM (mean age 58 ± 8.6 years and mean time of T2DM evolution 11.9 ± 8.2 years) and 40 nondiabetic subjects (mean age of 52.4 ± 10.9 years). Pure tone audiometry was performed with a Grason-Stadler GSI 18 screening audiometer, 11 frequencies (0.125–8 kHz) were evaluated and classified as low, medium, and high. Hearing loss was defined as a hearing threshold >20 decibels (dB) and was classified as: mild: 21–40 dB, moderate: 41–70 dB, severe: 71–90 dB, and profound: > 90 dB. Results: Compared to the control group, diabetic patients presented a significant increase in the hearing threshold at medium (P < 0.05) and high (P < 0.0001) audiometric frequencies. When hearing loss was present, it was almost entirely mild (>80%) in the control group, whereas diabetic patients presented moderate, severe, and even profound levels of hearing loss. A linear correlation was found between the diagnosis time of T2DM and the degree of hearing loss at high frequencies (P = 0.04) as well as at medium frequencies (P = 0.01). Conclusions: T2DM affects hearing from the early stages of the disease; routine evaluation of hearing function should be considered in this population.